Skip to main content
ADMA BIOLOGICS, INC. logo

ADMA BIOLOGICS, INC. — Investor Relations & Filings

Ticker · ADMA ISIN · US0008991046 US Manufacturing
Open in API
Filings indexed 962 across all filing types
Latest filing 2019-10-07 Capital/Financing Update
Country US United States of America
Listing US ADMA

About ADMA BIOLOGICS, INC.

https://www.admabiologics.com/

ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company that develops, manufactures, and commercializes specialty plasma-derived biologics. The company's portfolio features FDA-approved immune globulin (Ig) products for the treatment of immune-compromised patients and individuals at risk for certain infections. ADMA Biologics operates a vertically integrated manufacturing process for its specialty biologic products and utilizes a patented immunotechnology platform, which includes a proprietary microneutralization assay to measure neutralizing antibody levels in plasma. The company also offers contract manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2019
Capital/Financing Update Classification · 95% confidence The document is a 'Prospectus Supplement' filed pursuant to Rule 424(b)(7) related to the resale of shares by a selling stockholder. It provides detailed information about the selling stockholder, the number of shares offered, and the background of the share transfer. This type of document is a capital markets filing related to share offerings and resale registration, not a financial report, earnings release, or management discussion. It fits the definition of a Capital/Financing Update (CAP) as it updates on company fundraising and capital structure changes through share resale registration.
2019-10-07 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 7, 2019. It announces the issuance of a press release titled 'ADMA Biologics Announces Data Presented at IDWeek 2019' and includes the press release as an exhibit. The content is a brief announcement of an event and a press release, not a full financial report or detailed filing. The document length is 3081 characters, which is relatively short and consistent with an announcement rather than a full report. There is no substantive financial data or detailed analysis present. Therefore, this document fits the category of a Regulatory Filing (RNS), which is the fallback for miscellaneous SEC filings that do not fit other specific categories.
2019-10-07 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC by ADMA Biologics, Inc. It is a registration statement under the Securities Act of 1933 for the purpose of registering securities for sale to the public. The text includes details about the securities to be offered, the registration fee, and the prospectus describing the offering. This type of filing is related to capital raising activities and financing, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document is substantial in length (15,000 characters) and contains detailed registration information, not just an announcement or a brief notice, so it is not an RPA or RNS. Hence, the classification is CAP with high confidence.
2019-10-04 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 3, 2019. It announces a press release about a poster presentation at a conference (IDWeek 2019). The content is brief, primarily an announcement of an event and a press release, with no financial statements or detailed financial data. It does not contain quarterly or annual financial results, management discussion, or other report types. The document length is short (3091 characters), and it serves as a regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2019-10-03 English
Investor Presentation 2019
Investor Presentation Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated October 2, 2019. It announces that the company's executives will present an Investor Presentation at a healthcare conference, and the presentation slides are included as an exhibit. The text explicitly refers to the presentation as an "Investor Presentation" and includes the slides as Exhibit 99.1. There is no detailed financial report or earnings data, only a presentation overview and slides. The document is about the presentation event and materials, not a full financial report or earnings release. Therefore, the appropriate classification is Investor Presentation (IP). The document length is 4151 characters, which is consistent with a presentation announcement and slides, not a full report.
2019-10-02 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated September 23, 2019. It announces that the company's CEO and CFO will present a corporate overview at a healthcare conference on October 2, 2019. The document includes a press release as an exhibit but does not contain financial statements or detailed financial data. The length is 3256 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication of quarterly or annual financial results, audit information, or management discussion. The content is primarily an event announcement related to investor relations. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2019-09-23 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.